ArticleNature biomedical engineering2021

Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin.

Jung Seok Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.